| 000 | 01042 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515001547.0 | ||
| 264 | 0 | _c20051011 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/j.amjmed.2005.04.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaikh, David I | |
| 245 | 0 | 0 |
_aThe Vioxx debacle revisited. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cSep 2005 |
||
| 300 |
_a1057 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactones _xadverse effects |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xmethods |
| 650 | 0 | 4 | _aSocial Responsibility |
| 650 | 0 | 4 |
_aSulfones _xadverse effects |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tThe American journal of medicine _gvol. 118 _gno. 9 _gp. 1057 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2005.04.028 _zAvailable from publisher's website |
| 999 |
_c15798017 _d15798017 |
||